These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. [Efficacy of percutaneous transluminal renal angioplasty for pediatric renovascular hypertension: a meta-analysis]. Zhao X, Zhao L, Wu L, Zhang Y, Huang GY. Zhonghua Er Ke Za Zhi; 2020 Aug 02; 58(8):661-667. PubMed ID: 32842387 [Abstract] [Full Text] [Related]
34. Percutaneous transluminal renal artery angioplasty: who benefits most? Ziakka S, Belli AM, Kong TK, MacGregor GA, Missouris CG. Int J Clin Pract; 2002 Nov 02; 56(9):649-54. PubMed ID: 12469977 [Abstract] [Full Text] [Related]
35. Platelet-activating factor and anti-platelet-aggregating factor in acute reduction of blood pressure following percutaneous transluminal renal angioplasty in patients with renovascular hypertension. Masugi F, Ogihara T, Saeki S, Sakaguchi K, Kumahara Y. J Hum Hypertens; 1988 Aug 02; 2(2):111-6. PubMed ID: 2977405 [Abstract] [Full Text] [Related]
36. Percutaneous transluminal renal angioplasty in the treatment of renovascular hypertension in children. Fallo F, Oberfield SE, Levine LS, Stoner E, Greig F, Sniderman K, Saddekni S, Sos T, New MI. Clin Exp Hypertens A; 1986 Aug 02; 8(4-5):887-91. PubMed ID: 2944677 [Abstract] [Full Text] [Related]
37. Mid-aortic syndrome: a case report and review of the literature. Lin YJ, Hwang B, Lee PC, Yang LY, Meng CC. Int J Cardiol; 2008 Jan 24; 123(3):348-52. PubMed ID: 17321619 [Abstract] [Full Text] [Related]